These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1296645)

  • 1. Intradermal vaccination for hepatitis B.
    Woodruff BA; Moyer LA
    Clin Infect Dis; 1992 Dec; 15(6):1063-6. PubMed ID: 1296645
    [No Abstract]   [Full Text] [Related]  

  • 2. Intradermal hepatitis B vaccination: a systematic review and meta-analysis.
    Sangaré L; Manhart L; Zehrung D; Wang CC
    Vaccine; 2009 Mar; 27(12):1777-86. PubMed ID: 19200451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intradermal hepatitis B vaccination: five-year follow-up.
    Leonardi S; Barone P; Musumeci S
    Pediatr Infect Dis J; 1995 Aug; 14(8):716-7. PubMed ID: 8532435
    [No Abstract]   [Full Text] [Related]  

  • 4. [Intradermal hepatitis B vaccination in workers not responsive to intramuscular vaccination].
    Bauer H; Potasman I; Pick N
    Harefuah; 1998 Mar; 134(6):441-4, 503. PubMed ID: 10909572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of low-dose intradermal hepatitis B vaccination. Five years' experience of primary vaccination.
    Thompson SC; Darlington R; Tallent D; Robins-Browne R; Forsyth JR
    Med J Aust; 1993 Mar; 158(6):372-5. PubMed ID: 8479349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis B vaccination of health personnel. Intramuscular administration is the most expensive].
    Odén I; Jörbeck H
    Lakartidningen; 1994 Feb; 91(7):596-7. PubMed ID: 8114595
    [No Abstract]   [Full Text] [Related]  

  • 7. Intradermal hepatitis B vaccination of hospital personnel in developing countries.
    Arya SC
    Vaccine; 1994 Nov; 12(14):1356-7. PubMed ID: 7856304
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers.
    Henderson EA; Louie TJ; Ramotar K; Ledgerwood D; Hope KM; Kennedy A
    Infect Control Hosp Epidemiol; 2000 Apr; 21(4):264-9. PubMed ID: 10782589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    J Viral Hepat; 2011 Oct; 18(10):730-7. PubMed ID: 20819147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An early-type hypersensitivity (ETH) to hepatitis B surface antigen as a quick and economic screening test for a vaccination program.
    Barone P; Leonardi S; Oggiano R; Musumeci S
    Ann Ig; 1998; 10(2):121-4. PubMed ID: 9658674
    [No Abstract]   [Full Text] [Related]  

  • 12. A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting.
    Sangfelt P; Uhnoo I; Reichard O; Weiland O
    Scand J Gastroenterol; 2008; 43(4):465-72. PubMed ID: 18365912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccine administered by intradermal route in patients with celiac disease unresponsive to the intramuscular vaccination schedule: a pilot study.
    Leonardi S; Del Giudice MM; Spicuzza L; Spina M; La Rosa M
    Am J Gastroenterol; 2010 Sep; 105(9):2117-9. PubMed ID: 20818367
    [No Abstract]   [Full Text] [Related]  

  • 14. Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara).
    Roukens AH; Vossen AC; Boland GJ; Verduyn W; van Dissel JT; Visser LG
    Vaccine; 2010 Jun; 28(26):4288-93. PubMed ID: 20433806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) and intradermal hepatitis B vaccination.
    Nagafuchi S; Kashiwagi S; Hayashi J; Katsuta H; Ikematsu H; Harada M
    Fukuoka Igaku Zasshi; 2004 Dec; 95(12):305-13. PubMed ID: 15732372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series.
    Yousaf F; Gandham S; Galler M; Spinowitz B; Charytan C
    Ren Fail; 2015 Aug; 37(7):1080-8. PubMed ID: 26258528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intradermal vaccination: past experiences and current perspectives.
    Sticchi L; Alberti M; Alicino C; Crovari P
    J Prev Med Hyg; 2010 Mar; 51(1):7-14. PubMed ID: 20853670
    [No Abstract]   [Full Text] [Related]  

  • 19. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
    Morais EO; Resende MR; Oliveira AM; Sinkoc VM; Garcia MT; Angerami RN; da Silva LJ
    Aliment Pharmacol Ther; 2007 Apr; 25(7):849-55. PubMed ID: 17373924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches in hepatitis B vaccination for celiac disease.
    Filippelli M; Lionetti E; Pulvirenti A; Gennaro A; Lanzafame A; Marseglia GL; Salpietro C; Rosa ML; Leonardi S
    Immunotherapy; 2014; 6(8):945-52. PubMed ID: 25313572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.